Injectable Drugs Market, By Molecule Type (Small Molecule and Large Molecule), By Route of Administration (Intravenous, Intramuscular, Subcutaneous, Others), By Therapeutic Area (Oncology, Infectious Diseases, Autoimmune Disorders, Cardiovascular Diseases

Injectable Drugs Market, By Molecule Type (Small Molecule and Large Molecule), By Route of Administration (Intravenous, Intramuscular, Subcutaneous, Others), By Therapeutic Area (Oncology, Infectious Diseases, Autoimmune Disorders, Cardiovascular Diseases, Endocrinology, Neurology, Others), By Drug Class (Monoclonal Antibodies, Peptides and Proteins, Small Molecules, Immunoglobulins, Hormones, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)


Injectable drugs refer to medications that are administered directly into the body, mostly through veins, muscles or tissues. These are preferred over other drug delivery methods for various critical care therapies, owing to their ability to deliver medications directly into the bloodstream, ensuring rapid onset of action. Advancements in drug delivery technologies have led to development of novel injectable formulations with improved stability, solubility and bioavailability of active pharmaceutical ingredients. Growing prevalence of chronic diseases, rising focus on biologics and targeted drug therapies, and increasing demand for self-administered injectables can drive the market growth.

Market Dynamics:

Global injectable drugs market growth is driven by rising prevalence of chronic diseases such as cancer, diabetes and autoimmune disorders. According to WHO, chronic diseases are estimated to account for over 60% of global deaths. Rapid adoption of biologics and targeted drug therapies for treatment of cancer and autoimmune diseases can also drive the market growth. However, high costs associated with R&D and manufacturing of injectable products can pose challenges for the market players. Risk of needle-stick injuries while administering injectables can also hamper its adoption. Growing demand for self-administered injectables especially for management of chronic diseases can offer growth opportunities in the near future.

Key features of the study:
  • This report provides in-depth analysis of the global injectable drugs market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global injectable drugs market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Pfizer, Novartis, Sanofi, GlaxoSmithKline, Gilead Sciences and AbbVie
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global injectable drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global injectable drugs market
Detailed Segmentation-
  • By Molecule Type Insights (Revenue, USD Bn, 2019 - 2031)
  • Small Molecule
  • Large Molecule
  • By Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
  • Intravenous
  • Intramuscular
  • Subcutaneous
  • Others (Intradermal etc.)
  • By Therapeutic Area Insights (Revenue, USD Bn, 2019 - 2031)
  • Oncology
  • Infectious Diseases
  • Autoimmune Disorders
  • Cardiovascular Diseases
  • Endocrinology
  • Neurology
  • Others (Respiratory, Hematology, etc.)
  • By Drug Class Insights (Revenue, USD Bn, 2019 - 2031)
  • Monoclonal Antibodies
  • Peptides and Proteins
  • Small Molecules
  • Immunoglobulins
  • Hormones
  • Others (Vaccines, Biologics, etc.)
  • By Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Key Players Insights
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • AstraZeneca Plc
  • Merck & Co., Inc.
  • Viatris + Mylan N.V
  • Cipla Inc.
  • Dr Reddy’s Laboratories Ltd.
  • Samsung Biologics
  • Abbott Laboratories
  • Amgen Incorporated
  • Baxter International Incorporated
  • Becton Dickinson and Company
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline Plc
  • Roche Holding Limited


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drive Type
Market Snippet, By Vehicle Type
Market Snippet, By Sales Channel
Market Snippet, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Regulatory Scenario
Industry Trend
Merger and Acquisitions
New System Launches/Approvals
Impact of COVID-19 Pandemic
4. Global Automotive Drive Shaft Market, By Drive Type, 2019-2031, (US$ Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020-2031
Segment Trends
Rear-Wheel Drive
Introduction
Market Size and Forecast, 2019–2031, (US$ Bn)
All-Wheel Drive
Introduction
Market Size and Forecast, 2019–2031, (US$ Bn)
Front-Wheel Drive
Introduction
Market Size and Forecast, 2019–2031, (US$ Bn)
5. Global Automotive Drive Shaft Market, By Vehicle Type, 2019-2031, (US$ Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020-2031
Segment Trends
Passenger Cars
Introduction
Market Size and Forecast, 2019–2031, (US$ Bn)
Commercial Vehicles
Introduction
Market Size and Forecast, 2019–2031, (US$ Bn)
6. Global Automotive Drive Shaft Market, By Sales Channel, 2019-2031, (US$ Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020-2031
Segment Trends
OEM (Original Equipment Manufacturers)
Introduction
Market Size and Forecast, 2019–2031, (US$ Bn)
Aftermarket
Introduction
Market Size and Forecast, 2019–2031, (US$ Bn)
7. Global Automotive Drive Shaft Market, By Region, 2019-2031, (US$ Bn)
Introduction
Market Share Analysis, By Region, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020-2031
North America
Regional Trends
Market Size and Forecast, By Drive Type, 2019–2031, (US$ Bn)
Market Size and Forecast, By Vehicle Type, 2019–2031, (US$ Bn)
Market Size and Forecast, By Sales Channel, 2019–2031, (US$ Bn)
Market Size and Forecast, By Country, 2019–2031, (US$ Bn)
U.S.
Canada
Europe
Regional Trends
Market Size and Forecast, By Drive Type, 2019–2031, (US$ Bn)
Market Size and Forecast, By Vehicle Type, 2019–2031, (US$ Bn)
Market Size and Forecast, By Sales Channel, 2019–2031, (US$ Bn)
Market Size and Forecast, By Country, 2019–2031, (US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Regional Trends
Market Size and Forecast, By Drive Type, 2019–2031, (US$ Bn)
Market Size and Forecast, By Vehicle Type, 2019–2031, (US$ Bn)
Market Size and Forecast, By Sales Channel, 2019–2031, (US$ Bn)
Market Size and Forecast, By Country, 2019–2031, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Regional Trends
Market Size and Forecast, By Drive Type, 2019–2031, (US$ Bn)
Market Size and Forecast, By Vehicle Type, 2019–2031, (US$ Bn)
Market Size and Forecast, By Sales Channel, 2019–2031, (US$ Bn)
Market Size and Forecast, By Country, 2019–2031, (US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East & Africa
Regional Trends
Market Size and Forecast, By Drive Type, 2019–2031, (US$ Bn)
Market Size and Forecast, By Vehicle Type, 2019–2031, (US$ Bn)
Market Size and Forecast, By Sales Channel, 2019–2031, (US$ Bn)
Market Size and Forecast, By Country, 2019–2031, (US$ Bn)
South Africa
Israel
GCC Countries
Rest of the Middle East &Africa
8. Competitive Landscape
Company Profiles
American Axle & Manufacturing, Inc.
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments/Updates
BorgWarner Inc.
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments/Updates
GKN Automotive
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments/Updates
JTEKT Corporation
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments/Updates
Magna International Inc.
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments/Updates
NTN Corporation
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments/Updates
Rheinmetall Automotive AG
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments/Updates
Schaeffler AG
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments/Updates
SeAH Changwon Integrated Steel
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments/Updates
SKF Group
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments/Updates
Stellantis
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments/Updates
The Timken Company
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments/Updates
Tower International, Inc.
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments/Updates
Trelleborg AB
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments/Updates
ZF Friedrichshafen AG
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments/Updates
9. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
10. Research Methodology
References
Research Methodology
About us and Sales Contact
*Browse 60 market data tables and 40 figures on Automotive Drive Shaft Market - Global forecast to 2031”

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings